HCI Equity Partners Announces Agreement to Sell SDS Rx to DHL Supply Chain

• Transaction positions SDS Rx to continue delivering patient-centric, final-mile healthcare logistics under the ownership of a global leader

WASHINGTON, Sept. 10, 2025 /PRNewswire/ -- HCI Equity Partners ("HCI"), a lower middle market private equity firm, today announced that its portfolio company Strategic Delivery Solutions, LLC ("SDS Rx") has entered into a definitive agreement to be acquired by DHL Supply Chain, a business unit of DHL Group. Terms of the transaction were not disclosed. Closing is expected to occur by the end of 2025 and is subject to customary conditions and approvals.

SDS Rx is a leading final-mile logistics and specialty healthcare transportation provider serving long-term care and specialty pharmacies, radiopharmacies, and health system networks across the United States. The company specializes in high-touch, time-critical deliveries that support quality of care for patients and providers.

"We are genuinely excited about the future of SDS under DHL's ownership. This is a fantastic home for the business, and we're confident SDS will thrive and accelerate realization of its exciting growth opportunities. HCI would like to thank the SDS leadership team and employees for their outstanding dedication and partnership during our ownership. Their hard work and commitment to excellence have been instrumental in positioning the company for this next chapter," said Doug McCormick, Managing Partner at HCI Equity Partners.

Why HCI Believes DHL Is the Right Home for SDS Rx:

• Strategic fit: From HCI's perspective, SDS Rx's specialty final-mile expertise complements DHL's extensive life sciences and healthcare logistics platform, together offering broader solutions across the healthcare value chain.
• Customer focus: HCI believes DHL's scale and capabilities provide an excellent foundation to support SDS Rx's long-standing mission of patient-first service, ensuring customers continue to receive high-quality, reliable deliveries.
• People and operations: HCI is confident the combination offers continuity for SDS Rx employees and leadership, providing the resources of a global organization while preserving the strengths of the local teams that have driven the SDS's success.

About SDS Rx
SDS Rx provides final-mile delivery and specialty healthcare transportation services to long-term care and specialty pharmacies, radiopharmacies, and health system networks, with operations spanning more than 200 locations in the United States and capabilities that include same-day and expedited delivery.

About HCI Equity Partners
HCI Equity Partners is a private equity firm focused on investing in lower middle market companies and building scaled industry leaders in large, stable, fragmented end markets through organic initiatives and strategic M&A. The firm partners with management teams in sectors such as distribution, technician-based services, and basic manufacturing to drive sustainable value creation. For more information, visit www.hciequity.com.

Forward-Looking Statements
This press release may contain "forward-looking statements," including statements regarding the expected timing and completion of the transaction, integration plans, and future operations and performance. Forward-looking statements are based on current expectations and assumptions and involve risks and uncertainties that could cause actual results to differ materially. HCI undertakes no obligation to update any forward-looking statements to reflect events or circumstances after the date of this release.

Media Contact
Lambert by LLYC
Caroline Luz, [email protected], 203-570-6462

SOURCE HCI Equity Partners